Page last updated: 2024-11-06

fluquinconazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Fluquinconazole is a triazole antifungal agent with broad-spectrum activity against a variety of fungal pathogens. It is a synthetic compound that inhibits the biosynthesis of ergosterol, an essential component of fungal cell membranes. This inhibition disrupts fungal cell growth and viability. Fluquinconazole is primarily used in agriculture to control a wide range of fungal diseases in crops such as wheat, barley, and grapes. It is also used in veterinary medicine to treat fungal infections in animals. The compound is extensively studied due to its high efficacy and broad-spectrum activity against fungal infections. Research is ongoing to understand its mechanism of action, optimize its formulation, and develop new and more effective antifungal agents based on its structure. Fluquinconazole is important because it helps protect crops from fungal diseases, leading to increased yields and food security. It also plays a vital role in preventing and treating fungal infections in animals, contributing to animal health and welfare.'

fluquinconazole: a component of the pesticide Vision 250 SC [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

fluquinconazole : A member of the class of quinazolines that is 6-fluoroquinazolin-4-one carrying additional 1,2,4-triazol-1-yl and 2,4-dichlorophenyl substituents at positions 2 and 3 respectively. A fungicide used to control Ascomycetes, Deuteromycetes and Basidiomycetes spp. on cereals, beets and fruit. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID86417
CHEMBL ID481473
CHEBI ID83923
SCHEMBL ID21234
MeSH IDM0592828

Synonyms (31)

Synonym
3-(2,4-dichlorophenyl)-6-fluoro-2-(1,2,4-triazol-1-yl)quinazolin-4-one
CHEMBL481473
fluquinconazole
chebi:83923 ,
0ae2n0jni1 ,
ec 411-960-9
fluquinconazole [iso]
3-(2,4-dichlorophenyl)-6-fluoro-2-(1h-1,2,4-triazol-1-yl)quinazolin-4-(3h)-one
unii-0ae2n0jni1
136426-54-5
3-(2,4-dichlorophenyl)-6-fluoro-2-(1h-1,2,4-trizol-1-yl)quinazolin-4(3h)-one
castellan
AKOS015903631
SCHEMBL21234
jockey
fluquinconazole [mi]
3-(2,4-dichlorophenyl)-6-fluoro-2-(1h-1,2,4-triazol-1-yl)-4(3h)-quinazolinone
sn-597265
3-(2,4-dichlorophenyl)-6-fluoro-2-(1h-1,2,4-triazol-1-yl)quinazolin-4(3h)-one
vista
DTXSID5057965
IJJVMEJXYNJXOJ-UHFFFAOYSA-N
4(3h)-quinazolinone, 3-(2,4-dichlorophenyl)-6-fluoro-2-(1h-1,2,4-triazol-1-yl)-
fluquinconazole, pestanal(r), analytical standard
fluquinconazole 10 microg/ml in isooctane
J-006843
pesticide6_fluquinconazole_c16h8cl2fn5o_4(3h)-quinazolinone, 3-(2,4-dichlorophenyl)-6-fluoro-2-(1h-1,2,4-triazol-1-yl)-
Q1355196
EN300-244163
CS-0242063
3-(2,4-dichlorophenyl)-6-fluoro-2-(1h-1,2,4-triazol-1-yl)-3,4-dihydroquinazolin-4-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitorAn EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor that interferes with the action of EC 1.14.13.70 (sterol 14alpha-demethylase).
antifungal agrochemicalAny substance used in acriculture, horticulture, forestry, etc. for its fungicidal properties.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
quinazolinesAny organic heterobicyclic compound based on a quinazoline skeleton and its substituted derivatives.
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
triazolesAn azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms.
organofluorine compoundAn organofluorine compound is a compound containing at least one carbon-fluorine bond.
conazole fungicideAny conazole antifungal agent that has been used as a fungicide.
triazole fungicideAny triazole antifungal agent that has been used as a fungicide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (20)

Assay IDTitleYearJournalArticle
AID340956Antifungal activity against Candida krusei ATCC 6258 by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340961Antifungal activity against Candida albidus isolates from grapes by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340954Antifungal activity against Candida glabrata ATCC 90030 by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID341134Antifungal activity against Saccharomycopsis guttulata isolates from feeding stuff by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340955Antifungal activity against Candida krusei isolates from grapes and feeding stuffs by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340964Antifungal activity against Pichia anomala isolates from grapes by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340951Antifungal activity against Candida albicans isolates from animals by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID341133Antifungal activity against sSaccharomyces cerevisiae isolates from grapes by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340966Antifungal activity against Rhodotorula sp. isolates from grapes by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340950Antifungal activity against Candida albicans isolates from HIV infected patient during fluconazole therapy by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340959Antifungal activity against Candida parapsilosis ATCC 22013 by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340952Antifungal activity against Candida albicans isolates by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340962Antifungal activity against sCandida stellata isolates from grapes by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340953Antifungal activity against Candida glabrata isolates from feeding stuffs by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340949Antifungal activity against Candida albicans isolates from HIV infected patient before fluconazole therapy by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340965Antifungal activity against sKloeckera apiculata isolates from grapes by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340958Antifungal activity against Candida norvegensis isolates from grapes by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340957Antifungal activity against Candida lambica isolates from grapes by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340960Antifungal activity against Candida rugosa isolates from feeding stuff by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
AID340963Antifungal activity against Cryptococcus neoformans ATCC 90112 by NCCLS M27-A2 method2007Antimicrobial agents and chemotherapy, Aug, Volume: 51, Issue:8
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's2 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.08 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]